Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial | Zendy

Lucy N. John | Zendy; Camila González-Beiras | Zendy; Martí Vall-Mayans | Zendy; Reman Kolmau | Zendy; Wendy Houinei | Zendy; James Wangi | Zendy; Michael Marks | Zendy; Natàlia Casamitjana | Zendy

Open Access

Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial

Author(s) -

Lucy N. John,

Camila González-Beiras,

Martí Vall-Mayans,

Reman Kolmau,

Wendy Houinei,

James Wangi,

Michael Marks,

Natàlia Casamitjana

Publication year - 2021

Publication title -

the lancet regional health - western pacific

Language(s) - English

Resource type - Journals

ISSN - 2666-6065

DOI - 10.1016/j.lanwpc.2021.100293

Subject(s) - lymphatic filariasis , diethylcarbamazine , mass drug administration , medicine , ivermectin , azithromycin , albendazole , neglected tropical diseases , tropical disease , regimen , adverse effect , randomized controlled trial , clinical endpoint , surgery , population , filariasis , environmental health , antibiotics , disease , veterinary medicine , immunology , helminths , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research